First Time Loading...

Kamada Ltd
NASDAQ:KMDA

Watchlist Manager
Kamada Ltd Logo
Kamada Ltd
NASDAQ:KMDA
Watchlist
Price: 5.37 USD 2.87%
Updated: May 2, 2024
Section:
 

Relative Value

The Relative Value of one KMDA stock under the Base Case scenario is 6.7 USD. Compared to the current market price of 5.37 USD, Kamada Ltd is Undervalued by 20%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

KMDA Relative Value
Base Case
6.7 USD
Undervaluation 20%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

2.2
P/S
P/S
Price to Sales
2.2
vs History
39
vs Industry
80
Median 3Y
2.1
Median 5Y
2.1
Industry
8.1
Forward
1.9
More Details
37.3
P/E
P/E
Price to Earnings
37.3
vs History
20
vs Industry
5
Median 3Y
16.6
Median 5Y
12.4
Industry
26.2
Forward
23.4
More Details
71.5
P/OCF
P/OCF
Price to OCF
71.5
vs History
6
vs Industry
2
Median 3Y
12.2
Median 5Y
14.5
Industry
22.6
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
0
Median 3Y
14.6
Median 5Y
15.6
Industry
21.3
More Details
1.3
P/B
P/B
Price to Book Value
1.3
vs History
76
vs Industry
58
Median 3Y
1.3
Median 5Y
1.5
Industry
2.5
More Details
1.8
EV/S
EV/S
Enterprise Value to Sales
1.8
vs History
28
vs Industry
70
Median 3Y
1.7
Median 5Y
1.6
Industry
7.3
Forward
1.6
More Details
4.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
4.7
vs History
38
vs Industry
58
Median 3Y
4.6
Median 5Y
4.2
Industry
9.1
More Details
11.4
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
11.4
vs History
41
vs Industry
9
Median 3Y
12
Median 5Y
10
Industry
4.4
More Details
25.9
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
25.9
vs History
22
vs Industry
5
Median 3Y
18.4
Median 5Y
9.6
Industry
4.3
Forward
16.2
More Details
60.4
EV/OCF
EV/OCF
Enterprise Value to OCF
60.4
vs History
6
vs Industry
2
Median 3Y
11.1
Median 5Y
11.1
Industry
5.4
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
1
Median 3Y
9.3
Median 5Y
12.4
Industry
3.2
More Details
0.9
EV/IC
EV/IC
Enterprise Value to IC
0.9
vs History
65
vs Industry
60
Median 3Y
0.9
Median 5Y
1.6
Industry
5
More Details

Multiples Across Competitors

KMDA Competitors Multiples
Kamada Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IL
Kamada Ltd
NASDAQ:KMDA
308.7m USD 2.2 37.3 11.4 25.9
US
Abbvie Inc
NYSE:ABBV
281.3B USD 5.2 58.6 12.7 19.4
US
Amgen Inc
NASDAQ:AMGN
148.1B USD 5.3 22.1 16.4 24.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
103.8B USD 10.5 28.6 22.8 23.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
101.7B USD 7.6 25.4 16.9 18.6
AU
CSL Ltd
ASX:CSL
133B AUD 6.1 35.1 21.3 26.4
US
Gilead Sciences Inc
NASDAQ:GILD
81.3B USD 3 168.2 6.7 8.8
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Moderna Inc
NASDAQ:MRNA
45.8B USD 6.6 -9.6 -10.4 -8.9
US
Biogen Inc
NASDAQ:BIIB
31.3B USD 3.2 26.8 13.8 17.2
KR
Celltrion Inc
KRX:068270
38.9T KRW 17.9 72.5 44.4 61.1
EV/EBITDA Multiple
EBITDA Growth
IL
Kamada Ltd
NASDAQ:KMDA
Average EV/EBITDA: 18.5
11.4
N/A
US
Abbvie Inc
NYSE:ABBV
12.7
26%
US
Amgen Inc
NASDAQ:AMGN
16.4
62%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.8
59%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.9
50%
AU
CSL Ltd
ASX:CSL
21.3
54%
US
Gilead Sciences Inc
NASDAQ:GILD
6.7
18%
US
Seagen Inc
NASDAQ:SGEN
Negative Multiple: -61.9 N/A
US
Moderna Inc
NASDAQ:MRNA
Negative Multiple: -10.4 N/A
US
Biogen Inc
NASDAQ:BIIB
13.8
67%
KR
Celltrion Inc
KRX:068270
44.4
109%

See Also

Summary
KMDA intrinsic value, competitors valuation, and company profile.
DCF Valuation
KMDA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
KMDA stock valuation using valuation multiples.
Wall Street Estimates
KMDA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
KMDA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.